CD4 and melanoma: Martina et al. found that after co-incubating bone marrow-derived DCs with melanoma cell lysates and poly (I:C), derived exosomes could significantly promote proliferation of CD8+ and CD4+ T cells, thus enhancing the cytotoxicity of T cells to melanoma cells (Damo et al., 2015).